Indian J Med Sci About us | Subscription  |  Top cited articles | Contact Us | Feedback | Login   
Print this page Email this page   Small font size Default font size Increase font size 
 Users Online : 24
Home Current Issue Ahead of print Back Issues  Instructions Search e-Alerts
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (63 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


  In this article
   References
   Article Tables

 Article Access Statistics
    Viewed2174    
    Printed55    
    Emailed0    
    PDF Downloaded158    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 


 
LETTER TO EDITOR
Year : 2009  |  Volume : 63  |  Issue : 5  |  Page : 202-203
 

Paraneoplastic erythrocytosis as a primary presentation of hepatocellular carcinoma


Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore

Date of Web Publication4-Jul-2009

Correspondence Address:
Pik-Eu Chang
Department of Gastroenterology and Hepatology, Singapore General Hospital, Outram Road 169608
Singapore
Login to access the Email id


DOI: 10.4103/0019-5359.53167

PMID: 19584492

Get Permissions



How to cite this article:
Chang PE, Tan CK. Paraneoplastic erythrocytosis as a primary presentation of hepatocellular carcinoma. Indian J Med Sci 2009;63:202-3

How to cite this URL:
Chang PE, Tan CK. Paraneoplastic erythrocytosis as a primary presentation of hepatocellular carcinoma. Indian J Med Sci [serial online] 2009 [cited 2014 Oct 25];63:202-3. Available from: http://www.indianjmedsci.org/text.asp?2009/63/5/202/53167


Sir,

A 55-year-old man with hypertension, diabetes mellitus and gout presented with generalized lethargy and weight loss. He was diagnosed as a hepatitis B carrier 5 years ago but was not on regular follow-up and did not undergo regular liver function tests or ultrasound examinations. He smoked 20 cigarettes per day for the past 30 years. Clinical examination revealed facial plethora, mild scleral icterus and conjunctival suffusion. He had hepatomegaly with a hard, irregular liver. The patient was fully orientated with no asterixis. He had minimal ascites, numerous spider nevi (>6) and palmar erythema.

His hemoglobin count was elevated (21.5 g/dL) with a hematocrit concentration of 64.5%, indicative of polycythemia (erythrocytosis) [Table 1]. Serum erythropoietin level was elevated, indicating a secondary polycythemia. Liver function tests revealed a cholestatic picture with markedly elevated alfa-fetoprotein (AFP) level. Triphasic CT abdomen revealed an enhancing heterogenous mass in the liver, measuring 9.0 6.6 cm, in segments 5 and 6, with evidence of invasion and thrombosis of the right portal vein; and a metastatic deposit in the left adrenal gland.

The patient was diagnosed with advanced hepatocellular carcinoma (HCC) with portal vein thrombosis and adrenal metastasis, with paraneoplastic erythrocytosis due to increased tumor-related erythropoietin production. He underwent daily venesection for 4 days, which improved his hemoglobin to 17.9 g/dL. He was discharged well after 6 days but died suddenly 3 weeks later from an acute pulmonary embolism on a background of metastatic HCC.

Paraneoplastic syndromes occur when a cancer produces substances (hormones, cytokines or tumor-related proteins) which circulate in the bloodstream, affecting the function of other tissues at a site distant from the tumor origin. The prevalence of HCC-related paraneoplastic erythrocytosis ranges from 1% to 3%. [1],[2] The underlying pathophysiology of HCC-related paraneoplastic erythrocytosis is multi-factorial. Firstly, local hypoxia from focal hepatic tumor necrosis leads to compensatory production of erythropoietin by the kidneys. Secondly, tumor cells themselves can directly produce erythropoietin in response to hypoxia. Thirdly, certain HCC cells are capable of producing "ectopic erythropoietin" even in the absence of tissue hypoxia. [3] Direct evidence of erythropoietin production by HCC cells was demonstrated by electron microscopy and immunohistochemistry of HCC tissue from patients with paraneoplastic erythrocytosis. [4] HCC-related paraneoplastic erythrocytosis is significantly associated with large tumor volume, markedly elevated AFP levels, advanced disease and reduced survival. [5] The high erythropoietin levels in such patients are a reflection of the advanced disease and large tumor burden.

This case illustrates the importance of regular surveillance of hepatitis B carriers as they are 100 times more likely to develop liver cancer compared to uninfected individuals. Furthermore, the development of HCC in these patients may occur in the absence of symptoms or signs. As the incidence of HCC continues to rise, such paraneoplastic syndromes are likely to be encountered with increasing frequency. It is therefore important to recognize that erythrocytosis may be secondary to underlying HCC. This will aid in a more timely diagnosis of HCC, thus expediting appropriate treatment.

 
  References Top

1.Huh UY, Kim JH, Kim BH, Nam KD, Jang JY, Kim NH, et al. The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma. Korean J Hepatol 2005;11:275-83 [article in Korean].  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Trotter JF, Cohn A, Grant R. Erythrocytosis in a patient with hepatocellular carcinoma. J Clin Gastroenterol 2002;35:365-6.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Matsuyama M, Yamazaki O, Horii K, Higaki I, Kawai S, Mikami S, et al. Erythrocytosis caused by an erythropoietin-producing hepatocellular carcinoma. J Surg Oncol 2000;75:197-202.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Sakisaka S, Watanabe M, Tateishi H, Harada M, Shakado S, Mimura Y, et al. Erythropoeitin production in hepatocellular carcinoma cells associated with polycythemia: Immunohistochemical evidence. Hepatology 1993;18:1357-62.  Back to cited text no. 4    
5.Luo JC, Hwang SJ, Wu JC, Lai CR, Li CP, Chang FY, et al. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. Hepatogastroenterology 2002;49:1315-9.  Back to cited text no. 5  [PUBMED]  



 
 
    Tables

  [Table 1]

This article has been cited by
1 Epidemiology and Prognosis of Paraneoplastic Syndromes in Hepatocellular Carcinoma
Pik Eu Chang,Wai Choung Ong,Hock Foong Lui,Chee Kiat Tan
ISRN Oncology. 2013; 2013: 1
[Pubmed]
2 Erythrocytosis after liver transplantation: The experience of a university hospital
Gabriella Cordone, Fabiana Zingone, Giuseppe Cardillo, Vincenzo Martinelli, Novella Pugliese, Lucienne Pellegrini, Carolina Ciacci, Gianpaolo Parrilli
Liver Transplantation. 2013; : n/a
[VIEW]



 

Top
Print this article  Email this article
Previous article Next article

    

2004 - Indian Journal of Medical Sciences
Published by Medknow
Online since 15th December '04